CD274 and diffuse large B-cell lymphoma: Recurrent mutations activating the oncogenic JAK-STAT (and Notch) pathways and frequent amplifications of 9p24.1 contributing to immune escape via PD-L1 overexpression were described in EBV+ DLBCL patients.